Successfully Managing Disease-Specific Registries with eClinical Technology
Successfully Managing Disease-Specific Registries with eClinical Technology
4 PagesResearch Challenge T-Cell Lymphoma represents a rare heterogeneous group of diseases that accounts for 10-15 percent of all non-Hodgkin’s Lymphomas (NHLs) in the Western world. Peripheral T-Cell Lymphomas (PTCLs), responsible for the majority of T-Cell NHLs in adult patients, are often aggressive and therefore require aggressive treatment. Traditionally, patients with newly diagnosed PTCL have been managed with chemotherapy regimens designed
